Innate Pharma S.A. (IPHA)
NASDAQ·Healthcare·Biotechnology
$1.81
+1.01%
Mkt Cap $150.90M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+176.5%
Consensus $5.00 vs current $1.81
NASDAQ·Healthcare·Biotechnology
$1.81
+1.01%
Mkt Cap $150.90M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+176.5%
Consensus $5.00 vs current $1.81